Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-10570718
  • Global Drug Delivery Technology Market- Technologies, Market share and Industry Forecast to 2024

  • Publish: June 2018 | Report Code: HHE-10570718

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Drug Delivery Technology Market Report

Drug delivery technology refers to the usage of drug releasing technologies for the transport of a pharmaceutical compound (for instance, a pharmaceutical drug) in the body to achieve its desired therapeutic effect safely. Global drug delivery technology market is expected to rise with the CAGR of about 7.1% during forecast period 2017-2024. Technological advancements in drug delivery technology, launch of new and innovative products by the market players across the globe, etc. are some of the major growth promoters for global drug delivery technology market during forecast period.

Growth in biologics to fuel growth in global drug delivery technology market

Growth in biologics across the globe is one of the major factors that contributes towards the growth of global drug delivery technology market during forecast period. According to the DCAT Value Chain Insights, biologics accounted for about 24% of global pharmaceutical sales in 2015. Also, according to the Biotechnology Innovation Organization (BIO, United States), global biologics industry witnessed a growth of about 7% annually during 2011 and 2016. Such growth witnessed in the biologics industry is expected to fuel adoption and development of drug delivery technologies and would promote the growth of global drug delivery technology market during forecast period.

 

 

Source: OBRC Analysis

The report on global drug delivery technology market is segmented on the basis of route of administration, facility of use and stakeholders.

Route of administration segment in global drug delivery technology market includes:

·         Oral Drug Delivery

o   Solid Oral Drugs

§  Capsules

§  Pills

§  Powders

§  Tablets

o   Liquid Oral Drugs

§  Solutions

§  Syrups

o   Semi-Solid Oral Drugs

§  Elixirs

§  Emulsions

§  Gels

·         Pulmonary Drug Delivery

o   Formulations

o   Devices

§  Metered Dose Inhalers

§  Dry Powder Inhalers

§  Nebulizers

·         Jet Nebulizers

·         Soft Mist Nebulizers

·         Ultrasonic Nebulizers

·         Injectable Drug Delivery

o   Devices

§  Conventional Injection Devices

·         By Material

·         Glass

·         Plastic

·         By Product

o   Fillable Syringes

o   Prefilled Syringes

·         By Usability

o   Disposable Syringes

o   Reusable Syringes

§  Self-Injection Devices

·         Autoinjectors

·         Needle-Free Injectors

·         Pen Injectors

·         Wearable Injectors

§  Other Injector Devices

o   Formulations

§  Conventional Drug Delivery

§  Long-Acting Injection Formulations

§  Novel Drug Delivery Formulations

·         Ocular Drug Delivery

o   Formulations

§  Liquid Formulations

·         Eye Drops

·         Liquid Sprays

§  Semi-Solid Formulations

·         Eye Ointments

·         Gels

o   Ocular Devices

§  Drug-Coated Contact Lenses

§  Ocular Inserts

·         Nasal Drug Delivery

o   Nasal Drops

o   Nasal Gels

o   Nasal Powders

o   Nasal Sprays

·         Topical Drug Delivery

o   Formulations

§  Liquid Topical Drug Delivery

·         Solutions

·         Suspensions

§  Semi-Solid Topical Drug Delivery

·         Creams

·         Gels

·         Lotions

·         Ointments

·         Pastes

§  Solid Topical Drug Delivery

·         Powders

·         Suppositories

o   Devices (Transdermal Drug Delivery)

§  Transdermal Gels

§  Transdermal Patches

·         Implantable Drug Delivery

o   Active Implantable Drug Delivery

o   Passive Implantable Drug Delivery

·         Transmucosal Drug Delivery

o   Oral Transmucosal Drug Delivery

§  Buccal Drug Delivery

§  Sublingual Drug Delivery

o   Other Transmucosal Drug Delivery

§  Rectal Transmucosal Drug Delivery

§  Vaginal Transmucosal Drug Delivery

Facility of use segment in global drug delivery technology market includes:

·         Hospitals

·         Ambulatory Surgical Centers/Clinics

·         Home Care Settings

·         Diagnostic Centers

·         Other Facilities of Use

Stakeholders segment of global drug delivery technology market are divided as:

·         Raw material suppliers

·         Manufacturers

·         Distributors and Logistics

 

Global drug delivery technology market covers segmentation analysis of route of administration and facility of use. Report further covers segments of route of administration which includes oral drug delivery (solid oral drugs, liquid oral drugs and semi-solid oral drugs), pulmonary drug delivery (formulations and devices), injectable drug delivery (formulations and devices), ocular drug delivery (formulations and ocular devices), nasal drug delivery (nasal drops, nasal sprays, nasal powders and nasal gels), topical drug delivery (formulations and ocular devices), implantable drug delivery (active implantable drug delivery and passive implantable drug delivery) and transmucosal drug delivery (oral transmucosal drug delivery and other transmucosal drug delivery). Topical drug delivery is expected to be the fastest growing segment in global drug delivery technology market during the forecast period. Advantages offered by topical drug delivery such as convenience and ease of use, noninvasiveness, ease of dosage, enhanced patient compliance, etc. majorly contributes towards its fastest growth during the forecast period. Further, the facility of use segment is divided as hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers and other facilities of use.

The report scope and market revenue estimates & forecast of global drug delivery technology market is widely categorized on the basis of its segments such as of route of administration, facility of use and stakeholders.

Geographically, global drug delivery technology market report has been segmented in:

·         North America (U.S. & Canada)

·         Asia Pacific (China, India, Japan, RoAPAC)

·         Europe (UK, France, Germany, RoE)

·         Rest of World

North America dominates global drug delivery technology market

North America accounted for the largest market share in terms of revenue for global drug delivery technology market followed by other regions in 2017. North America is expected to dominate the market during forecast period. High prevalence of chronic diseases such as cancer, cardio vascular diseases, diabetes, etc. coupled with presence of majority of market players across the region and growth in healthcare infrastructure of the region are some of the major factors that contributes towards the largest market revenue share of North America in drug delivery technology market during the forecast period. However, Asia Pacific is expected to be the fastest growing region in drug delivery technology market during forecast period. Factors such as investments by major companies in research and development, low costs of labor, increasing clinical trials, etc. majorly contributes towards the fastest growth rate of Asia Pacific in drug delivery technology market during the forecast period.

The major market players of global drug delivery technology market are:

·         BAYER AG (GERMANY)

·         GLAXOSMITHKLINE PLC (UNITED KINGDOM)

·         MERCK & CO., INC. (UNITED STATES)

·         NOVARTIS AG (SWITZERLAND)

·         PFIZER, INC. (UNITED STATES)

·         OTHERS

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch whereas partnership and collaboration is the key strategy adopted by the companies in global drug delivery technology market.

For example, in 2016, Bayer AG (Germany) partnered (collaboration and technology license agreement) with DelSiTech (Finland based drug delivery technology and drug development market player) for the development of innovative drug delivery technology (Silica Matrix drug delivery platform) for ophthalmology. This is expected to increase the dominance of the company by increasing its market revenue share.

In 2018, Novartis AG (Switzerland) collaborated with Wyss Institute for Biologically Inspired Engineering at Harvard University (United Sates) and Dana-Farber Cancer Institute (United Sates) for the development of biomaterial systems for immuno-oncology therapies. This would overcome limitations of conventional cancer vaccines, such as lack of targeting to specific cancer cells and limited duration of action. The licensing agreement with Office of Technology Development of Harvard University and collaboration with the Wyss Institute would support the company to develop combination immunotherapy regimens. This is expected to increase the dominance of the company by increasing its market revenue share.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in global drug delivery technology market.

Key reasons to buy the report:

·         The report includes market estimation, forecast and analysis of global drug delivery technology market for the forecast year 2017-2024.

·         Report includes detailed analysis of different segments such as route of administration and facility of use of global drug delivery technology market during the forecast period.

·         Identify and understand the strengths, opportunities, challenges and threats of global drug delivery technology market during forecast period.

·         Covers detailed analysis of Porter’s 5 force model and other strategic models. Also covers revenues, market share analysis, and competitive landscape analysis of major players of the global drug delivery technology market during forecast period.

·         Detailed analysis of various regulatory policies which are affecting the global drug delivery technology market during the forecast period. 

How are we different from others?

At Occams, we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on the global drug delivery technology market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the global drug delivery technology market, with giving extensive SCOT analysis of key companies.

Key findings of the global drug delivery technology market:

·         Growth in biologics is one of the major factors that is expected to contribute towards the growth of global drug delivery technology market during the forecast period.

·         Asia Pacific is expected to be the fastest growing region in global drug delivery technology market during the forecast period.

·         Topical drug delivery is expected to be the fastest growing segment in the global drug delivery technology market by route of administration segment during the forecast period.

·         Partnership and collaboration is the key strategy adopted by the companies in the global drug delivery technology market during the forecast period.  

 

 

 

  1. INTRODUCTION
    1. EXECUTIVE SUMMARY
    2. ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    1. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET: EVOLUTION & TRANSITION
    2. MARKET DEFINITION & SCOPE
    3. INDUSTRY STRUCTURE
    4. REGULATORY FRAMEWORK
    5. TOTAL MARKET ANALYSIS
      1. TOP 5 FINDINGS
      2. TOP 5 OPPORTUNITY MARKETS
      3. TOP 5 COMPANIES
      4. TOP 3 COMPETITIVE STRATEGIES
    6. ESTIMATION ANALYSIS
    7. STRATEGIC ANALYSIS
      1. INVESTMENT VS. ADOPTION MODEL
      2. 360-DEGREE INDUSTRY ANALYSIS
      3. PORTERS 5 FORCE MODEL
      4. SEE-SAW ANALYSIS
      5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    8. COMPETITIVE ANALYSIS
      1. KEY STRATEGIES & ANALYSIS
      2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
    9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      1. INVESTMENT OPPORTUNITIES BY REGIONS
      2. OPPORTUNITIES IN EMERGING APPLICATIONS
      3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  3. MARKET DETERMINANTS
    1. MARKET DRIVERS
      1. GROWTH IN BIOLOGICS INDUSTRY
      2. INCREASING PREVALENCE OF CHRONIC DISEASES
      3. TECHNOLOGICAL ADVANCEMENTS WITH LAUNCH OF NEW PRODUCTS
      4. INCREASING DEMAND FOR EFFECTIVE DELIVERY MECHANISMS OF NOVEL BIOPHARMACEUTICALS
    2. MARKET RESTRAINTS
      1. PRODUCT RECALLS AND FAILURES
      2. SIDE EFFECTS OF DRUGS COUPLED WITH RISK ASSOCIATED WITH NEEDLESTICK INJURIES
    3. MARKET OPPORTUNITIES
      1. INCREASING DEMAND FOR GENERIC DRUGS AND BIOSIMILARS
      2. INCREASING FOCUS ON HOME CARE AND SELF-ADMINISTRATION
    4.   MARKET CHALLENGES
      1. PATENT CLIFF AND EXPIRY
      2. PRICING PRESSURE
  4. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION
    1. MARKET DEFINITION AND SCOPE
    2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    4. OPPORTUNITY MATRIX
    5. MARKET SEGMENTATION
      1. GLOBAL ORAL DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. SOLID ORAL DRUGS
            1. CAPSULES
            2. PILLS
            3. POWDERS
            4. TABLETS
          2. LIQUID ORAL DRUGS
            1. SOLUTIONS
            2. SYRUPS
          3. SEMI-SOLID ORAL DRUGS
            1. ELIXIRS
            2. EMULSIONS
            3. GELS
      2. GLOBAL PULMONARY DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. FORMULATIONS
          2. DEVICES
            1. METERED DOSE INHALERS
            2. DRY POWDER INHALERS
            3. NEBULIZERS
              1. JET NEBULIZERS
              2. SOFT MIST NEBULIZERS
              3. ULTRASONIC NEBULIZERS
      3. GLOBAL INJECTABLE DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. DEVICES
            1. CONVENTIONAL INJECTION DEVICES
              1. BY MATERIAL
              2. GLASS
              3. PLASTIC
              4. BY PRODUCT
                1. FILLABLE SYRINGES
                2. PREFILLED SYRINGES
              5. BY USABILITY
                1. DISPOSABLE SYRINGES
                2. REUSABLE SYRINGES
            2. SELF-INJECTION DEVICES
              1. AUTOINJECTORS
              2. NEEDLE-FREE INJECTORS
              3. PEN INJECTORS
              4. WEARABLE INJECTORS
            3. OTHER INJECTOR DEVICES
          2. FORMULATIONS
            1. CONVENTIONAL DRUG DELIVERY
            2. LONG-ACTING INJECTION FORMULATIONS
            3. NOVEL DRUG DELIVERY FORMULATIONS
      4. GLOBAL OCULAR DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. FORMULATIONS
            1. LIQUID FORMULATIONS
              1. EYE DROPS
              2. LIQUID SPRAYS
            2. SEMI-SOLID FORMULATIONS
              1. EYE OINTMENTS
              2. GELS
          2. OCULAR DEVICES
            1. DRUG-COATED CONTACT LENSES
            2. OCULAR INSERTS
      5. GLOBAL NASAL DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. NASAL DROPS
          2. NASAL GELS
          3. NASAL POWDERS
          4. NASAL SPRAYS
      6. GLOBAL TOPICAL DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. FORMULATIONS
            1. LIQUID TOPICAL DRUG DELIVERY
              1. SOLUTIONS
              2. SUSPENSIONS
            2. SEMI-SOLID TOPICAL DRUG DELIVERY
              1. CREAMS
              2. GELS
              3. LOTIONS
              4. OINTMENTS
              5. PASTES
            3. SOLID TOPICAL DRUG DELIVERY
              1. POWDERS
              2. SUPPOSITORIES
          2. DEVICES (TRANSDERMAL DRUG DELIVERY)
            1. TRANSDERMAL GELS
            2. TRANSDERMAL PATCHES
      7. GLOBAL IMPLANTABLE DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. ACTIVE IMPLANTABLE DRUG DELIVERY
          2. PASSIVE IMPLANTABLE DRUG DELIVERY
      8. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
        5. MARKET SUB-SEGMENTS
          1. ORAL TRANSMUCOSAL DRUG DELIVERY
            1. BUCCAL DRUG DELIVERY
            2. SUBLINGUAL DRUG DELIVERY
          2. OTHER TRANSMUCOSAL DRUG DELIVERY
            1. RECTAL TRANSMUCOSAL DRUG DELIVERY
            2. VAGINAL TRANSMUCOSAL DRUG DELIVERY
  5. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY FACILITY OF USE
    1. MARKET DEFINITION AND SCOPE
    2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    4. OPPORTUNITY MATRIX
    5. MARKET SEGMENTATION
      1. GLOBAL HOSPITALS MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
      2. GLOBAL AMBULATORY SURGICAL CENTERS/CLINICS MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
      3. GLOBAL HOME CARE SETTINGS MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
      4. GLOBAL DIAGNOSTIC CENTERS MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
      5. GLOBAL OTHER FACILITIES OF USE MARKET
        1. ADOPTION SCENARIO & MARKET DETERMINANTS
        2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
        3. KEY PLAYERS & KEY PRODUCTS
        4. KEY CONCLUSIONS
  6. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY  STAKEHOLDERS
    1. MARKET DEFINITION AND SCOPE
    2. MARKET SEGMENTATION
      1. GLOBAL RAW MATERIAL SUPPLIER MARKET
      2. GLOBAL MANUFACTURER MARKET
      3. GLOBAL DISTRIBUTOR AND LOGISTICS MARKET
  7. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIES
      1. LIST OF MERGERS AND ACQUISITION
      2. LIST OF JOINT VENTURES
      3. LIST OF PRODUCT LAUNCHES
      4. LIST OF PARTNERSHIPS
  8. GEOGRAPHIC ANALYSIS
    1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    3. OPPORTUNITY MATRIX
    4.  GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY REGION 2015-2024  
      1. NORTH AMERICA
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. U.S.
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          2. CANADA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
      2. EUROPE
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. UK
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          2. FRANCE
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          3. GERMANY
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          4. SPAIN
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          5. REST OF EUROPE
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY  PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
      3. ASIA PACIFIC
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. CHINA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          2. INDIA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          3. JAPAN
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          4. AUSTRALIA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY  PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          5. REST OF ASIA PACIFIC
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY  PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
      4. ROW
        1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
        2. TOP COUNTRY ANALYSIS
          1. LATIN AMERICA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
          2. MIDDLE EAST & AFRICA
            1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
            2. KEY PLAYERS & KEY PRODUCTS
            3. KEY CONCLUSIONS
  9. COMPANY PROFILES
    1. 3M COMPANY (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    2. ALKERMES (REPUBLIC OF IRELAND)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    3. ANTARES PHARMA, INC. (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    4. BAYER AG (GERMANY)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    5. BECTON, DICKINSON AND COMPANY (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    6. F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    7. GENEREX BIOTECHNOLOGY (CANADA)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    8. GLAXOSMITHKLINE PLC (UK)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    9. JOHNSON & JOHNSON SERVICES, INC. (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    10. MERCK & CO., INC. (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    11. NOVARTIS AG (SWITZERLAND)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    12. PFIZER, INC. (U.S.)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    13. PSIVIDA CORPPRATION (U.S.)
      1. OVERVIEW 
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    14. SANOFI S.A. (FRANCE)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS
    15. VECTURA GROUP PLC (UK)
      1. OVERVIEW
      2. PRODUCT PORTFOLIO
      3. STRATEGIC INITIATIVES
      4. SCOT ANALYSIS
      5. STRATEGIC ANALYSIS

LIST OF TABLES

  1. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  2. GLOBAL ORAL DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  3. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY ORAL DRUG DELIVERY 2015-2024 ($ MILLION)
  4. GLOBAL ORAL DRUG DELIVERY MARKET BY SOLID ORAL DRUGS 2015-2024 ($ MILLION)
  5. GLOBAL ORAL DRUG DELIVERY MARKET BY LIQUID ORAL DRUGS 2015-2024 ($ MILLION)
  6. GLOBAL ORAL DRUG DELIVERY MARKET BY SEMI-SOLID ORAL DRUGS 2015-2024 ($ MILLION)
  7. GLOBAL PULMONARY DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  8. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY PULMONARY DRUG DELIVERY 2015-2024 ($ MILLION)
  9. GLOBAL PULMONARY DRUG DELIVERY MARKET BY DEVICES 2015-2024 ($ MILLION)
  10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET BY NEBULIZERS 2015-2024 ($ MILLION)
  11. GLOBAL INJECTABLE DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  12. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY INJECTABLE DRUG DELIVERY 2015-2024 ($ MILLION)
  13. GLOBAL INJECTABLE DRUG DELIVERY MARKET BY DEVICES 2015-2024 ($ MILLION)
  14. GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET BY CONVENTIONAL INJECTION DEVICES 2015-2024 ($ MILLION)
  15. GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY PRODUCT 2015-2024 ($ MILLION)
  16. GLOBAL CONVENTIONAL INJECTION DEVICES MARKET BY USABILITY 2015-2024 ($ MILLION)
  17. GLOBAL INJECTABLE DRUG DELIVERY DEVICES MARKET BY SELF-INJECTION DEVICES 2015-2024 ($ MILLION)
  18. GLOBAL INJECTABLE DRUG DELIVERY MARKET BY FORMULATIONS 2015-2024 ($ MILLION)
  19. GLOBAL OCULAR DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  20. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY OCULAR DRUG DELIVERY 2015-2024 ($ MILLION)
  21. GLOBAL OCULAR DRUG DELIVERY MARKET BY FORMULATIONS 2015-2024 ($ MILLION)
  22. GLOBAL OCULAR DRUG DELIVERY FORMULATIONS MARKET BY LIQUID FORMULATIONS 2015-2024 ($ MILLION)
  23. GLOBAL OCULAR DRUG DELIVERY FORMULATIONS MARKET BY SEMI-SOLID FORMULATIONS 2015-2024 ($ MILLION)
  24. GLOBAL OCULAR DRUG DELIVERY MARKET BY OCULAR DEVICES 2015-2024 ($ MILLION)
  25. GLOBAL NASAL DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  26. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY NASAL DRUG DELIVERY 2015-2024 ($ MILLION)
  27. GLOBAL TOPICAL DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  28. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TOPICAL DRUG DELIVERY 2015-2024 ($ MILLION)
  29. GLOBAL TOPICAL DRUG DELIVERY MARKET BY FORMULATIONS 2015-2024 ($ MILLION)
  30. GLOBAL TOPICAL DRUG DELIVERY FORMULATIONS MARKET BY LIQUID TOPICAL DRUG DELIVERY 2015-2024 ($ MILLION)
  31. GLOBAL TOPICAL DRUG DELIVERY FORMULATIONS MARKET BY SEMI-SOLID TOPICAL DRUG DELIVERY 2015-2024 ($ MILLION)
  32. GLOBAL TOPICAL DRUG DELIVERY FORMULATIONS MARKET BY SOLID TOPICAL DRUG DELIVERY 2015-2024 ($ MILLION)
  33. GLOBAL TOPICAL DRUG DELIVERY MARKET BY DEVICES 2015-2024 ($ MILLION)
  34. GLOBAL IMPLANTABLE DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  35. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY IMPLANTABLE DRUG DELIVERY 2015-2024 ($ MILLION)
  36. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  37. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY TRANSMUCOSAL DRUG DELIVERY 2015-2024 ($ MILLION)
  38. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY ORAL TRANSMUCOSAL DRUG DELIVERY 2015-2024 ($ MILLION)
  39. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY OTHER TRANSMUCOSAL DRUG DELIVERY 2015-2024 ($ MILLION)          
  40. GLOBAL DRUG DELIVERY TECHNOLOGY MARKET BY FACILITY OF USE 2015-2024 ($ MILLION)
  41. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  42. GLOBAL AMBULATORY SURGICAL CENTERS/CLINICS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  43. GLOBAL HOME CARE SETTINGS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  44. GLOBAL DIAGNOSTIC CENTERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  45. GLOBAL OTHER FACILITIES OF USE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
  46. NORTH AMERICA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  47. EUROPE DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  48. ASIA PACIFIC DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  49. REST OF THE WORLD DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  50. NORTH AMERICA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  51. EUROPE DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  52. ASIA PACIFIC DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  53. REST OF THE WORLD DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  54. NORTH AMERICA DRUG DELIVERY TECHNOLOGY MARKET BY FACILITY OF USE 2015-2024 ($ MILLION)
  55. EUROPE DRUG DELIVERY TECHNOLOGY MARKET BY FACILITY OF USE 2015-2024 ($ MILLION)
  56. ASIA PACIFIC DRUG DELIVERY TECHNOLOGY MARKET BY FACILITY OF USE 2015-2024 ($ MILLION)
  57. REST OF THE WORLD DRUG DELIVERY TECHNOLOGY MARKET BY FACILITY OF USE 2015-2024 ($ MILLION)
  58. UNITED STATES DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  59. CANADA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  60. UK DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  61. FRANCE DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  62. GERMANY DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  63. SPAIN DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  64. ROE DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  65. CHINA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  66. INDIA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  67. JAPAN DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  68. AUSTRALIA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  69. ROAPAC DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  70. LATIN AMERICA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)
  71. MENA DRUG DELIVERY TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION 2015-2024 ($ MILLION)

 

LIST OF FIGURES

  1. GLOBAL ORAL DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  2. GLOBAL PULMONARY DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  3. GLOBAL INJECTABLE DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  4. GLOBAL OCULAR DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  5. GLOBAL NASAL DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  6. GLOBAL TOPICAL DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  7. GLOBAL IMPLANTABLE DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  8. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET 2015-2024 ($ MILLION)
  9. GLOBAL HOSPITALS MARKET 2015-2024 ($ MILLION)
  10. GLOBAL AMBULATORY SURGICAL CENTERS/CLINICS MARKET 2015-2024 ($ MILLION)
  11. GLOBAL HOME CARE SETTINGS MARKET 2015-2024 ($ MILLION)
  12. GLOBAL DIAGNOSTIC CENTERS MARKET 2015-2024 ($ MILLION)
  13. GLOBAL OTHER FACILITIES OF USE MARKET 2015-2024 ($ MILLION)
  1. UNITED STATES (U.S.) DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  2. CANADA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  3. UNITED KINGDOM (UK) DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  4. FRANCE DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  5. GERMANY DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  6. SPAIN DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  7. ROE DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  8. INDIA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  9. CHINA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  10. JAPAN DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  11. AUSTRALIA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  12. ROAPAC DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  13. LATIN AMERICA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)
  14. MENA DRUG DELIVERY TECHNOLOGY MARKET 2015-2024 ($ MILLION)

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion